| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Jan 24, 2025 | Sale | $0.45 | 22,258 | 10,094 | 490,980 | Jan 27, 2025, 06:15 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Oct 07, 2024 | Sale | $0.57 | 67,695 | 38,329 | 452,060 | Oct 08, 2024, 04:44 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Sep 09, 2024 | Sale | $0.66 | 2,642 | 1,738 | 289,110 | Sep 11, 2024, 04:01 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Mar 11, 2024 | Sale | $0.88 | 15,409 | 13,591 | 291,752 | Mar 11, 2024, 05:19 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Feb 12, 2024 | Sale | $1.01 | 3,683 | 3,709 | 307,161 | Feb 12, 2024, 05:23 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Nov 01, 2023 | Sale | $0.73 | 67,695 | 49,417 | 310,844 | Nov 03, 2023, 04:40 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Sep 08, 2023 | Sale | $1.25 | 2,642 | 3,300 | 147,894 | Sep 12, 2023, 04:04 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Jun 23, 2023 | Sale | $1.93 | 857 | 1,654 | 151,000 | Jun 26, 2023, 04:15 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Jun 15, 2023 | Sale | $2.23 | 857 | 1,911 | 151,857 | Jun 16, 2023, 04:24 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Mar 10, 2023 | Sale | $0.84 | 18,192 | 15,281 | 152,714 | Mar 13, 2023, 04:52 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Mary Dibiase | Chief Operating Officer | Feb 13, 2023 | Sale | $0.93 | 4,348 | 4,044 | 170,906 | Feb 15, 2023, 05:13 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More